Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chiesi Italia
With
Gesellschaft für Therapieforschung mbH
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients ≥ 18 years of age;
Patients with confirmed leading diagnosis of asthma with or without concomitant COPD;
Physician decision to start fixed triple therapy with ICS/LABA/LAMA (BDP/FF/G) MS or HS according to its current authorised indication and current reimbursement conditions within the Italian National Health System. The treatment decision must be made independently from participation in this study and may have started within the previous 4 weeks (maximum);
Patients willing and able to sign an informed consent for use of their pseudonymised clinical data within the present non-interventional study.
You may not be if
Participation in an interventional clinical trial within 30 days prior to enrolment into the present non-interventional study or planned enrolment in an interventional clinical trial during the observational period.
Clareo Health | Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting
